CytoDyn (CYDY) Amortizatization of Intangibles (2011 - 2025)
CytoDyn (CYDY) posted Amortizatization of Intangibles of $59000.0 for Q2 2025, down 46.36% on a QoQ basis from $110000.0 in Q1 2025, and down 52.8% year-over-year from $125000.0 in Q2 2024.
CytoDyn (CYDY) Amortizatization of Intangibles (2011 - 2025) Analysis & Trends
CytoDyn's Amortizatization of Intangibles history runs 14 years deep, the most recent figure standing at $59000.0 for Q2 2025.
- Quarterly Amortizatization of Intangibles fell 52.8% year-over-year to $59000.0 in Q2 2025, while the trailing twelve-month figure through May 2025 was $407000.0 (down 62.17% YoY) and the FY2025 annual result came in at $407000.0, down 62.17% from the prior year.
- Amortizatization of Intangibles was $59000.0 for Q2 2025 at CytoDyn, down from $110000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $952000.0 in Q3 2021 and bottomed at $59000.0 in Q2 2025.
- A 5-year average of $420888.9 and a median of $407000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles soared 326.0% — and 2023, when it tumbled 75.52%.
- CytoDyn's Amortizatization of Intangibles stood at $793000.0 in 2021, then retreated by 26.86% to $580000.0 in 2022, then slumped by 75.52% to $142000.0 in 2023, then decreased by 20.42% to $113000.0 in 2024, then slumped by 47.79% to $59000.0 in 2025.
- Business Quant data shows CYDY's Amortizatization of Intangibles at $59000.0 in Q2 2025, $110000.0 in Q1 2025, and $113000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | CytoDyn | 258.22 Mn | 258.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 59,000.00 |
| May 31, 2025 | 59,000.00 |
| Feb 28, 2025 | 110,000.00 |
| Feb 28, 2025 | 110,000.00 |
| Nov 30, 2024 | 113,000.00 |
| Nov 30, 2024 | 113,000.00 |
| Aug 31, 2024 | 125,000.00 |
| Aug 31, 2024 | 125,000.00 |
| May 31, 2024 | 125,000.00 |
| May 31, 2024 | 125,000.00 |
| Feb 29, 2024 | 409,000.00 |
| Feb 29, 2024 | 409,000.00 |
| Nov 30, 2023 | 142,000.00 |
| Nov 30, 2023 | 142,000.00 |
| Aug 31, 2023 | 400,000.00 |
| Aug 31, 2023 | 400,000.00 |
| May 31, 2023 | 405,000.00 |
| May 31, 2023 | 405,000.00 |
| Feb 28, 2023 | 565,000.00 |
| Feb 28, 2023 | 565,000.00 |